Diazyme Laboratories Competitors and Similar CompaniesClear all
KalVista Pharmaceuticals's competitors and similar companies include Oncquest Laboratories and Intelligent Bio Solutions.
 KalVista Pharmaceuticals KalVista Pharmaceuticals is an ophthalmology company focused on developing drugs for the treatment of diabetic macular edema (DME). |  Intelligent Bio Solutions GBS (formerly known as Glucose Biosensor Systems (Greater China) Holdings) is a biosensor diagnostic technology company. | ||
Founding Date | Founding Date 2011 | Founding Date 2003 | Founding Date N/A |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Porton Down, GB HQ Cambridge, US | Locations New Delhi, IN HQ | Locations New York, US HQ Barangaroo, AU |
Employees | Employees 150 | Employees 746 | Employees 1623% increase |
Valuation ($) | Valuation ($) 523.4 m | Valuation ($) N/A | Valuation ($) 7 m |
Financial | |||
Revenue (est.) | Revenue (est.) $49.1m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $3.1m (FY, 2025) |
Cost of goods | Cost of goods $3.1m (FY, 2025) | Cost of goods N/A | Cost of goods $1.8m (FY, 2025) |
Gross profit | Gross profit $46m (FY, 2025) | Gross profit N/A | Gross profit $1.2m (FY, 2025) |
Net income | Net income ($109.5m) (FY, 2025) | Net income N/A | Net income ($10.6m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Intelligent Bio Solutions
HQ
New York, US
Employees
16↑ 23% increase
GBS (formerly known as Glucose Biosensor Systems (Greater China) Holdings) is a biosensor diagnostic technology company.
View company